Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:40AM ET
0.0606
Dollar change
+0.0036
Percentage change
6.32
%
Index- P/E- EPS (ttm)-1.18 Insider Own7.55% Shs Outstand99.45M Perf Week1.00%
Market Cap6.03M Forward P/E- EPS next Y- Insider Trans1.62% Shs Float91.94M Perf Month7.83%
Income-26.77M PEG- EPS next Q-0.03 Inst Own11.83% Short Float1.06% Perf Quarter-79.03%
Sales20.35M P/S0.30 EPS this Y- Inst Trans-13.41% Short Ratio0.06 Perf Half Y-80.48%
Book/sh0.86 P/B0.07 EPS next Y- ROA-78.14% Short Interest0.97M Perf Year-91.59%
Cash/sh0.19 P/C0.32 EPS next 5Y- ROE-85.87% 52W Range0.04 - 1.40 Perf YTD-77.68%
Dividend Est.- P/FCF- EPS past 5Y54.97% ROI-118.87% 52W High-95.67% Beta-1.09
Dividend TTM- Quick Ratio4.11 Sales past 5Y565.10% Gross Margin35.06% 52W Low38.04% ATR (14)0.01
Dividend Ex-Date- Current Ratio5.00 EPS Y/Y TTM-102.31% Oper. Margin-42.43% RSI (14)39.73 Volatility9.16% 17.38%
Employees46 Debt/Eq0.03 Sales Y/Y TTM4046.13% Profit Margin-131.52% Recom1.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q67.10% Payout- Rel Volume0.58 Prev Close0.06
Sales Surprise-0.71% EPS Surprise33.33% Sales Q/Q4385.93% EarningsNov 14 AMC Avg Volume15.50M Price0.06
SMA205.32% SMA50-52.03% SMA200-80.53% Trades Volume672,903 Change6.32%
Mar-04-24 09:18AM
Feb-15-24 09:15AM
Feb-13-24 09:00AM
Dec-04-23 08:30AM
Nov-13-23 08:30AM
09:05PM Loading…
Sep-21-23 09:05PM
Aug-11-23 08:30AM
May-16-23 02:15PM
09:58AM
May-12-23 08:00AM
May-11-23 09:00AM
Apr-05-23 08:00AM
Feb-28-23 07:30AM
Feb-10-23 07:35AM
Jan-19-23 07:30AM
08:00AM Loading…
Dec-27-22 08:00AM
Dec-20-22 08:00AM
Nov-23-22 11:20AM
Nov-16-22 10:12AM
08:00AM
Nov-13-22 07:52AM
Nov-07-22 09:28AM
Oct-20-22 08:00AM
07:32AM
Aug-08-22 08:15AM
Aug-04-22 08:00AM
Jul-28-22 08:10AM
Jun-27-22 05:30AM
Apr-28-22 04:50PM
09:20AM
08:13AM Loading…
Apr-26-22 08:13AM
12:41AM
Apr-25-22 08:00AM
Apr-19-22 06:45PM
02:02PM
Apr-08-22 09:44AM
Apr-05-22 03:45PM
01:41PM
08:00AM
07:30AM
Mar-15-22 09:45AM
Mar-14-22 06:12PM
Mar-10-22 09:17AM
Feb-25-22 08:00AM
Feb-17-22 10:40AM
10:07AM
Feb-15-22 09:00AM
Dec-22-21 08:52AM
Nov-03-21 12:35PM
Oct-06-21 08:00AM
Aug-12-21 09:00AM
Jul-27-21 09:00AM
Jul-20-21 09:00AM
Jul-08-21 09:00AM
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerMar 04 '24Buy0.10100,00010,000130,000Mar 05 04:05 PM
Slilaty Steve N.Chief Executive OfficerFeb 08 '24Buy0.1020,0002,00030,000Feb 12 04:05 PM